Subscribe to RSS - ResMed

ResMed

ResMed strengthens COPD play

 - 
12/04/2018

SAN DIEGO – ResMed has entered into a definitive agreement to buy Propeller Health, a company that provides connected health solutions for people living with COPD and asthma, for $225 million.

People news: Sullivan, Distasio, Lowman, Turner, Gill, Stone

 - 
11/29/2018

Connie Sullivan has been named president and CEO of the National Home Infusion Association.

In brief: VGM provides talking points, Viemed shares take hit

 - 
11/20/2018

WATERLOO, Iowa – The VGM Group has pulled together suggested talking points for providers who plan to comment on CMS’s proposal to include vents in its next round of competitive bidding.

ResMed’s board members honored

 - 
11/20/2018

SAN DIEGO – Two members of ResMed’s board of directors have been named to WomenInc. Magazine’s “2018 Most Influential Corporate Directors,” a list of women executives, influencers and achievers contributing leadership to corporate boards.

ResMed expands software portfolio

 - 
11/06/2018

SAN DIEGO – ResMed has signed a definitive agreement to acquire privately held MatrixCare, a provider of long-term, post-acute care software, for $750 million.

ResMed becomes platinum sponsor

 - 
11/01/2018

SAN DIEGO – ResMed has stepped up its support of AAHomecare, moving from a gold-level to a platinum level corporate partner—the highest sponsorship level for the association.

ResMed: Watch for Mobi POC early next year

Company officials also comment on growth for CPAP devices, ‘blip’ in growth for Brightree
 - 
10/26/2018

SAN DIEGO – ResMed is still keeping its plans for the Mobi portable oxygen concentrator largely under wraps.

ResMed sees 12% increase in revenue

 - 
10/26/2018

SAN DIEGO – ResMed reported revenue of $588.3 million for the first quarter of fiscal year 2019, a 12% increase over the same period in 2018. It reported a net income of $105.7 million vs. $86.1 million, a 23% increase.

ResMed wins in German court

 - 
10/23/2018

SAN DIEGO – A trial court ruling from the Munich District Court says the headgear used on two CPAP masks from Fisher & Paykel Healthcare—the Simplus full-face and Eson nasal—infringes a ResMed patent in Germany.

OSA affects more Europeans than previously thought, ResMed says

 - 
09/19/2018

PARIS – Approximately 175 million Europeans have obstructive sleep apnea, including 90 million with moderate to severe OSA, according to an abstract presented by ResMed at the European Respiratory Society’s annual ERS Congress.

Pages